0
Deep & Emerging Tech·July 24, 2026·1 min read

FDA advisers vote against sleep peptide as they debate safety and health claims

Share

FDA advisers pushing back on a popular sleep peptide—and reviewing seven wellness peptides overall—signals a tighter line on compounded “biohacking” products. Wellness and telehealth operators should expect more scrutiny on claims and compounding practices and get ahead of it with data, labeling, and alternative SKUs.